Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- RPIndependent statistical analysis of REAL Parenting Alcohol and Substance Use App: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03932097).
- RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).
- RPDIndependent statistical analysis of Reciprocating Medical Devices - a Study of a New Safety Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: Complete Statistical AnalysisIndependent statistical analysis of rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02498067).
- RPNIIndependent statistical analysis of Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: Complete Statistical AnalysisIndependent statistical analysis of RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313351).
- RRRIndependent statistical analysis of Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.: primary endpoint…
- RSLV-132Independent statistical analysis of A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03247686).
- RSV OA=ADJ-023Independent statistical analysis of A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant…
- RSV-OA=ADJ-020Independent statistical analysis of A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence…
- RSVHRIndependent statistical analysis of A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery – GUARD: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RTDIndependent statistical analysis of Obtain a Good Blood Glucose Control With the Paradigm Real Time System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RTGIndependent statistical analysis of Room to Grow Evaluation for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226053).
- RTLS for Healthcare Process Validation: Complete Statistical AnalysisIndependent statistical analysis of RTLS for Healthcare Process Validation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116957).
- rTMSIndependent statistical analysis of rTMS for the Treatment of Chronic Pain in GW1 Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01608321).
- rTMS Bimodal Treatment For Tinnitus: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of rTMS Bimodal Treatment For Tinnitus: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590264).
- rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: Complete Statistical AnalysisIndependent statistical analysis of rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- rTMS to Enhance Cognitive Performance and Promote Resilience: Complete Statistical AnalysisIndependent statistical analysis of rTMS to Enhance Cognitive Performance and Promote Resilience: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04123496).
- rTMS-FPCCIndependent statistical analysis of Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- rTMSECTIndependent statistical analysis of rTMS in Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080507).
- RTSSIndependent statistical analysis of Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02992119).
- RUBATOIndependent statistical analysis of Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): primary endpoint results, effect…
- Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RuRaLIndependent statistical analysis of Hypocaloric Nutrition in Critically Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01531335).
- Rural Home Hospital: Proof of Concept: Complete Statistical AnalysisIndependent statistical analysis of Rural Home Hospital: Proof of Concept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531280).
- Rural NDPPIndependent statistical analysis of The National Diabetes Prevention Program in Rural Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05387434).
- Rutgers Pilot for PREDICT- Patient LAB Test: Complete Statistical AnalysisIndependent statistical analysis of Rutgers Pilot for PREDICT- Patient LAB Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05607043).
- Ruxolitinib and Lenalidomide for Patients With Myelofibrosis: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib and Lenalidomide for Patients With Myelofibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01375140).
- Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02267278).
- Ruxolitinib for Adult T-Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib for Adult T-Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01712659).
- Ruxolitinib for Cancer Cachexia: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib for Cancer Cachexia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04906746).
- Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ruxolitinib in Seborrheic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Seborrheic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05787860).
- Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours: Complete Statistical AnalysisIndependent statistical analysis of RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03199872).
- RVA FlavorsIndependent statistical analysis of Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RVD LiteIndependent statistical analysis of Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01782963).
- RVDDIndependent statistical analysis of Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RVEcIndependent statistical analysis of Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RVIIndependent statistical analysis of REVITIVE for the Treatment of Patients With Venous Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02114307).
- RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study: Complete Statistical AnalysisIndependent statistical analysis of RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RYR1Independent statistical analysis of Antioxidant Therapy in RYR1-Related Congenital Myopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02362425).
- S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00475176).
- S-CASTIndependent statistical analysis of Smoking-Cessation and Stimulant Treatment (S-CAST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01077024).
- S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma: Complete Statistical AnalysisIndependent statistical analysis of S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00006237).
- S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…